What this study is
This early phase I trial studies how well a behavioral weight loss intervention consisting of a smartphone application and coaching works for the promotion of weight loss in adolescents and young adults after a stem cell transplant. This study may help researchers learn more about how adolescents and young adults can lose weight and develop healthy eating habits.
What's being tested
- Interview
Intervention · OTHER
Participate in interviews
- Media Intervention
Intervention · OTHER
Receive iPhone with W8Loss2Go app
- Questionnaire Administration
Intervention · OTHER
Complete questionnaires
- Scale Device
Intervention · OTHER
Receive body scale and food scale
- Telephone-Based Intervention
Intervention · BEHAVIORAL
Receive telephone calls
- Text Message
Intervention · OTHER
Receive text message
Study details
- Official title
- Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients (BWL001)
- Sponsor
- Jonsson Comprehensive Cancer Center
- Conditions
- Obesity · Malignant Neoplasm
- Enrolling
- 20 people
- Starts
- 2020-07-01
- Est. completion
- 2027-12-31
- Design
- Open-label, single group
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 13 Years – 30 YearsSex ALLHealthy volunteers AcceptedYou may qualify if
- Patients with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study
- Patients must classify as obese, represented as body mass index (BMI) >= 85th percentile for age and gender
- Patients must also be able to read English since the app intervention is only available in English form
- No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation
- PARENT:
- His/her child meets all inclusion criteria
- >= 18 years of age
- Can speak English
You can't join if
- Patients who are < 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are > 100 days post-transplant at their next consultation that falls within the enrollment window
- Patients whose BMI does not fall under the obese category will be excluded
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openUCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Theodore B. Moore · Contact310-794-8929tbmoore@mednet.ucla.edu
- Theodore B. Moore · Principal investigator
Recruiting
Study team
Sponsor
Jonsson Comprehensive Cancer Center
Study ID 19-001992
Principal investigator
Theodore B Moore
UCLA / Jonsson Comprehensive Cancer Center
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.